These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28039419)

  • 1. Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study.
    Hsu CY; Lin MS; Su YJ; Cheng TT; Lin YS; Chen YC; Chiu WC; Chen TH
    Rheumatology (Oxford); 2017 Apr; 56(4):620-628. PubMed ID: 28039419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sjögren's syndrome: a nationwide retrospective case-control study in Taiwan.
    Tseng HW; Huang WC; Lu LY
    Clin Exp Rheumatol; 2019; 37(6):946-952. PubMed ID: 31074727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
    Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
    Zamora LD; Collante MTM; Navarra SV
    Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
    Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
    Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
    Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study.
    Hsu CY; Lin YS; Su YJ; Lin HF; Lin MS; Syu YJ; Cheng TT; Yu SF; Chen JF; Chen TH
    Rheumatology (Oxford); 2017 Dec; 56(12):2212-2221. PubMed ID: 29029334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study.
    Yeo KJ; Chen HH; Chen YM; Lin CH; Chen DY; Lai CM; Chao WC
    BMC Infect Dis; 2020 Feb; 20(1):112. PubMed ID: 32041539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
    Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
    Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
    Akawatcharangura P; Taechakraichana N; Osiri M
    Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study.
    Guo J; Ren Z; Li J; Li T; Liu S; Yu Z
    Arthritis Res Ther; 2020 Jun; 22(1):159. PubMed ID: 32586407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjögren's syndrome.
    Hsu BC; Chen YH; Lin CH; Tang KT
    Int J Rheum Dis; 2022 Dec; 25(12):1424-1430. PubMed ID: 36089698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study.
    Wu YD; Lin CH; Chao WC; Liao TL; Chen DY; Chen HH
    PLoS One; 2017; 12(10):e0187075. PubMed ID: 29059229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    Garnier C; Ribes D; Chauveau D; Huart A; Pugnet G; Adoue D; Prevot G; Alric L; Delobel P; Derumeaux H; Mengelle C; Sailler L; Moulis G
    J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor.
    Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
    Int J Rheum Dis; 2019 Mar; 22(3):468-472. PubMed ID: 30406967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis.
    Arnaud L; Nordin A; Lundholm H; Svenungsson E; Hellbacher E; Wikner J; Zickert A; Gunnarsson I
    Arthritis Rheumatol; 2017 Jun; 69(6):1272-1279. PubMed ID: 28141919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study.
    Chang CM; Wu PC; Chiang JH; Wei YH; Chen FP; Chen TJ; Pan TL; Yen HR; Chang HH
    J Ethnopharmacol; 2017 Jan; 196():201-212. PubMed ID: 27974236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
    Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
    Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.